Patents by Inventor Manfred Erdmann

Manfred Erdmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline form and acetic acid adducts of palbociclib
    Patent number: 10526326
    Abstract: The present invention relates to an adduct of palbociclib, a method of preparing the preparing the same, and a pharmaceutical composition comprising the same. More particularly, the invention provides a crystalline form of palbociclib, a method of preparing the same, as well as a pharmaceutical composition comprising the same.
    Type: Grant
    Filed: July 12, 2016
    Date of Patent: January 7, 2020
    Assignee: ratiopharm GmbH
    Inventors: Jens Geier, Wolfgang Albrecht, Ludovic Coutable, Manfred Erdmann
  • Acid addition salt of ibrutinib
    Patent number: 10059715
    Abstract: The present invention relates to acid addition salts of ibrutinib, a pharmaceutical composition comprising the same as well as a method of preparing the same.
    Type: Grant
    Filed: August 25, 2015
    Date of Patent: August 28, 2018
    Assignee: Ratiopharm GmbH
    Inventors: Sebastian Rabe, Manfred Erdmann, Wolfgang Albrecht
  • NEW CRYSTALLINE FORM AND ACETIC ACID ADDUCTS OF PALBOCICLIB
    Publication number: 20180222903
    Abstract: The present invention relates to an adduct of palbociclib, a method of preparing the same, as well as a pharmaceutical composition comprising the same.
    Type: Application
    Filed: July 12, 2016
    Publication date: August 9, 2018
    Inventors: Jens GEIER, Wolfgang ALBRECHT, Ludovic COUTABLE, Manfred ERDMANN
  • ACID ADDITION SALT OF IBRUTINIB
    Publication number: 20170305914
    Abstract: The present invention relates to acid addition salts of ibrutinib, a pharmaceutical composition comprising the same as well as a method of preparing the same.
    Type: Application
    Filed: August 25, 2015
    Publication date: October 26, 2017
    Applicant: ratiopharm GmbH
    Inventors: Sebastian RABE, Manfred ERDMANN, Wolfgang ALBRECHT
  • Diethylene glycol monoester derivatives, compositions and therapeutic use
    Patent number: 4960793
    Abstract: Novel diethylene glycol monoester of antirheumatically effective acids, e.g., lonazolac and diclofenac and others are disclosed which have inflammation inhibitory properties superior to the corresponding acid base forms. They may be produced through direct esterification without elimination of water and are suitable in the fight against diseases of the rheumatic complex.
    Type: Grant
    Filed: March 31, 1989
    Date of Patent: October 2, 1990
    Assignee: Merckle GmbH
    Inventors: Gunter Metz, Kurt Rauchle, Manfred Erdmann